Elanco Animal Health Gets Its Bite Back, Pipeline Efforts Earn Praise
1. Elanco's core business stabilizes, prompting stock upgrades from analysts. 2. New product launches in livestock and pet health position Elanco for growth. 3. Zenrelia's approval expected; could drive product demand significantly. 4. Competition with Zoetis and Merck poses challenges for market share. 5. Analysts predict five percentage points growth from new products by 2025.